Respiratory system diseases are common and frequently occurring illnesses. Influenza virus infections, mycoplasma infections, seasonal allergen triggers, smoking habits, etc., can all induce respiratory system diseases to a certain extent. Among these, the incidence of diseases such as silicosis, lung cancer, bronchial asthma, etc., has significantly increased, with chronic obstructive pulmonary disease continuing to occupy a high proportion. Since the outbreak of COVID-19, the combined use of traditional Chinese and Western medicine has shown notable efficacy. Traditional Chinese medicine has played an important role in the prevention, control, and treatment of the epidemic, making significant contributions. Ethnic medicine is an important element in the cultural heritage of Chinese medicine and the culture of ethnic minorities. Dai medicine, as an important component of this, has a relatively complete medical theoretical system and research foundation, showing certain efficacy in the prevention and treatment of many diseases and holding significant socio-cultural value. Therefore, this analysis and research were conducted on how to further explore and develop research on the treatment of respiratory diseases with Dai medicine prescriptions and to promote the screening of these prescriptions to form a complete clinical evaluation system.